BioHealth News Archive
TruGenomix just won Start Up of the Year Pitch Event
Excited to announce that TruGenomix just won Start Up of the Year Pitch Event. Great pitch Charles Cathlin !!!!! #SDVOB #ptsd #TruGenomix #veteranshelpingveterans
Read More
Emergent Bio inks deal with AstraZeneca for manufacture of COVID-19 vaccine (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (NYSE:EBS) has signed an agreement with AstraZeneca (NYSE:AZN) to provide contract development and manufacturing (CDMO) services for large-scale drug substance manufacturing for AZN's…
Read More
Undergraduate Scholarships
Each scholarship is a one-time award; however previous applicants and past scholarship recipients are eligible to re-apply. Full-time, part-time, online and distance learning programs…
Read More
AstraZeneca mines another $6B ADC from Daiichi Sankyo, with blockbuster ambitions to ‘redefine treatment standards’ – Endpoints News
Pascal Soriot isn’t letting the all-consuming R&D and manufacturing work on a Covid-19 vaccine slow down his hunt for AstraZeneca’s next blockbuster cancer drugs.…
Read More
Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate NYSE:EBS
GAITHERSBURG, Md., July 27, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an agreement to provide contract development…
Read More
“COVID-19 edition” of pediatric medical device
WASHINGTON – (July 22, 2020) – The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces eight winners chosen in its special COVID-19 edition…
Read More
Sanford Health and TruGenomix announce partnership to commercialize genomic test for PTSD
SIOUX FALLS, S.D., July 23, 2020 /PRNewswire/ -- Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in…
Read More
Maryland VC funding defies dire pandemic predictions, rises in Q2 – Technical.ly Baltimore
When it comes to Maryland companies, the pandemic isn’t slowing down venture capital funding. Data from the latest MoneyTree report by PricewaterhouseCoopers/CB Insights shows…
Read More
Incoming international students must remain abroad despite visa rule reversal – The Johns Hopkins News-Letter
“Today, we feel forgotten. Everyone believes we still won. The class of 2024 didn’t win. After calls and emails, we’re met with another unyielding…
Read More
Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
GAITHERSBURG, Md. and MORRISVILLE, N.C., July 23, 2020 /PRNewswire/ -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,…
Read More
Altimmune Announces Manufacturing Agreement with Vigene Biosciences for AdCOVID™, its Single Dose Intranasal Vaccine Candidate for COVID-19 Nasdaq:ALT
GAITHERSBURG, Md., July 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the Company has entered into…
Read More
University System of Maryland chancellor describes rationale for fall plans | WTOP
Since May, the University System of Maryland has said that remote learning and in-person classes will return in the fall. It recently explained why…
Read More
Alexandria LaunchLabs – Only Two Small Labs Left!
Alexandria LaunchLabs™ in Maryland, will provide fully equipped, affordable laboratory/office space with flexible lease terms, supporting infrastructure, access to amenities, and supporting services and…
Read More
TEDCO names Troy LeMaile-Stovall as next CEO – Technical.ly Baltimore
TEDCO, Maryland’s state-backed agency that supports early-stage tech companies, has named Troy LeMaile-Stovall as its next CEO. Lemaile-Stovall, who is currently COO of the…
Read More
In conversation with Vaccitech CEO Enright on pandemic vaccines | FierceBiotech
Vaccitech is a spinout company from the University of Oxford's Jenner Institute, one of the oldest and most renowned vaccine research centers in the…
Read More